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We studied the outcome of 79 pregnancies in 44 Saudi women who had epilepsy. Their mean age was 28  6:5 years and
the number of pregnancies studied varied from one to six. Nineteen subjects had generalized seizures, 16 had partial seizures
and nine were unclassified. The commonest drug prescribed was carbamazepine and the majority of the women (61%) were
on monotherapy. The seizures were controlled in 53 pregnancies (67%). Spontaneous vertex deliveries were the commonest.
The indications for intervention by lower segment Caesarean section, forceps or ventouse were foetal distress, pre-eclamptic
toxaemia (PET), eclampsia, breech presentation and prolonged labour. The most frequent adverse outcome in the babies was
low birth weight (<2:5 kg) in nine pregnancies. The frequency of congenital malformation was 2.5%. Low birth weight was
associated with prematurity, PET, congenital malformation and polytherapy. Avoidance of polytherapy appears to be the most
feasible intervention in reducing the frequency of low birth-weight children by epileptic mothers.
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Successful management of epilepsy in pregnancy
incorporates seizure control, maintenance of good
health of the mother and delivery of a healthy baby.
The possible problems and complications that may
arise and could compromise the outcome include:
increased risk of maternal seizures due to altered
drug pharmacokinetics, risk of bleeding, toxaemia and
prematurity1–3. Additionally, exposure to antiepileptic
drugs (AED) in utero could be associated with con-
genital malformations in the baby1–6. We reviewed the
course of pregnancy in a group of female epileptic pa-
tients followed up in the neurology clinics to document
the outcome of pregnancy and the factors associated
with adverse outcome.
Materials and methods
The study took place at the King Khalid University
Hospital, Riyadh (KKUH) which is a teaching hospital
with approximately 600 beds. The hospital provides1059–1311/99/010026 + 04 $12.00/0secondary and tertiary care services. It attracts refer-
ral from all over the Kingdom. Health care is provided
free for all Saudis; however, there is no special bias for
delivery in KKUH.
Methodology
The antenatal and perinatal records of the pregnant
epileptic patients followed up in the neurology clinics
compiled by M. A. Bunyan (MAB) between 1985 and
1994 were examined. The information obtained on each
patient included: the duration of epilepsy, the seizure
type, seizure frequency during the index pregnancy,
the AED prescribed, compliance and serum drug lev-
els. We documented the previous obstetric history in-
cluding parity, mode of delivery and adverse outcomes
like congenital anomalies or stillbirth if any. For the in-
dex pregnancies we recorded: the last menstrual period
and the expected delivery date. The gestational age of
the baby at delivery was determined from these dates
and ultrasound scan findings. The type of delivery (i.e.
whether spontaneous vertex, Caesarean section, ven-
touse or others) was recorded.c© 1999 British Epilepsy Association
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Table 1: Pattern of drug prescription.
Drug Monotherapy Polytherapya Total
Carbamazepine (CBZ) 31 15 46
Phenytoin (PHT) 9 12 21
Valproate (VAL) 5 6 11
Phenobarbitone (PHB) 2 8 10
Clonazepam (CLO) 1 2 3
No drugsb — — 10
Totalc 48 21 79
aCombinations: PHTC CBZ D 8; CBZC PHB D 4; PHTC PHB
D 3; LBZC Val D 2; ValC PHB, ValC PHT, ValC CLO, ValC
CBZC CLO of 1 each.
b Seizures in remission for a long time.
c Monotherapy C Polytherapy C No drugs.
Table 2: Outcome of pregnancies—post-partum data.
Epileptic Non-epileptica Statistics
mothers
n D 79
Gestational age (weeks)
Mean 39:4 2:0 39:2 2:0 nsb
Mean Apgar score
1 minute 7:5 1:3 n/ac
2 minutes 8:9 0:8 n/a
Mean birth weightd (kg) 3:2 0:6 3:3 0:5 ns
Number < 2:5 kg 9 (11.5%) 338 (7.4%) ns
Number > 2:5 kg 69 (88.5%) 4578 (92.6%)
Mean birth length (cm) 48:8 2:9 49:7 2:5 ns
Mean head
circumference (cm) 33:7 1:7 34:4 1:4 ns
a Ref: 8–10;
b ns D not significant;
c n/a D not available;
d excludes one stillbirth.In patients who underwent surgical intervention the
indications for operative delivery were noted. The Ap-
gar scores of the babies at 1 and 5 minutes were derived
from the quality of heart rates, respiratory effort, mus-
cle tone and reflexes determined in the standard way.
The following measurements were made: occipito-
frontal head circumference, length and weight of each
baby. The weights were measured on electronic baby
scales (BSL 20A, FCG, Japan) with automatic reset-
ting to zero. The baby lengths were measured using
an infantometer supplied by Holtian Ltd (Crymych,
Dyfed, Wales UK). These methods have been previ-
ously described7. The post-partum examinations were
carried out by a paediatrician who documented any con-
genital anomalies present. The reasons for admission
of any baby to the neonatal intensive care units were
recorded where applicable.
Data analysis
We used frequency counts for all the variables. We
tested for association between pregnancy outcome and
the following: maternal age, duration of epilepsy, mode
of therapy using cross-tabulations, determination of the
odds ratio and chi-squared test statistics. We compared
the anthropometric measurements of the babies with
those from published literature on Saudi birth weights
(historical controls)7–9. Birth weights less than 2.5 kg
were regarded as low birth-weight infants7.
Results
A total of 79 pregnancies occurred in 44 women with
varying parity from one to 10 during the study period.
Twenty-four patients had one pregnancy each, 12 had
two, three had three and four had four pregnancies in
the hospital. One woman had six pregnancies during
the study period. The ages of the women ranged be-
tween 17 and 48 years with a mean of 28 years (SD
D 6.5 years). The mean age at onset of epilepsy was
18 years (SD D 6.4 years). Nineteen patients (43.2%)
had generalized seizures of whom 10 were of the myo-
clonic type and the remaining nine had tonic–clonic
seizures. Sixteen subjects (36.4%) had partial seizures,
of whom 10 were complex, five were secondarily gen-
eralized and one was simple. The remaining nine cases
were not classifiable. The seizures remained controlled
during 53 pregnancies (67%).
Table 1 shows the drug therapy during the pregnan-
cies. The most frequently prescribed drug was carba-
mazepine which was used as monotherapy during 31
pregnancies, and in combination with other drugs in
15 other pregnancies. In 10 pregnancies, the mothers
did not take AED because their seizures were in remis-sion and as a personal preference for fear of an adverse
outcome in their babies.
Spontaneous vertex deliveries for 63 pregnancies
(79.7%) were the most frequent. Lower segment Cae-
sarean section was performed for 10 pregnancies and
there were three deliveries each by ventouse and for-
ceps. The indications for intervention were: foetal dis-
tress (five cases), pre-eclamptic toxaemia (three cases),
elective procedure by a particular patient (three cases),
eclampsia (two cases) and one case because of breech
presentation, prolonged labour and obstructed labour
due to cephalopelvic disproportion. A summary of the
anthropometric measurements and Apgar scores of the
babies tabulated against the data for historical controls
in Saudi Arabia is presented in Table 2.
Two babies had congenital malformations. One of
them was delivered by a 39-year-old, gravida 11, whose
seizures were controlled by a combination of pheny-
toin and carbamazepine. That baby had dextrocardia
and oesophageal atresia. In addition, the baby had a
low birth weight and a low Apgar score. The second
baby had hydronephrosis and a low birth weight. The
second mother was controlled on carbamazepine only.
A third child with cardiomegaly was recorded, though
28 M. Al Bunyan & Z. Abo-Talibthere was no clinical evidence of congenital heart dis-
ease. His mother was a 35-year-old, gravida nine, who
had pre-eclamptic toxaemia. The same woman had a
previous baby with congenital heart disease. She was
on polytherapy of valproate, clonazepam and carba-
mazepine. The frequency of congenital malformation
in this study was 2.5%. One woman with juvenile myo-
clonic epilepsy on carbamazepine and phenytoin had a
stillbirth. That pregnancy was terminated at 32 weeks.
Two babies needed observation in a neonatal intensive
care unit because of meconium-stained liquor, and were
later discharged with no complications.
Low birth weight (lbw) was recorded in a total of
nine babies including two premature deliveries, three
cases of pre-eclamptic toxaemia, two babies born with
congenital malformations; the stillbirth at 32 weeks and
the baby of one 40-year-old, gravida eight, mother who
was not on AED. Out of the 10 pregnancies that had
obstetric or neonatal problems (including lbw), six of
them involved AED polytherapy (carbamazepine and
phenytoin in three cases; carbamazepine and phenobar-
bital in two cases and a combination of valproic acid,
clonazepam with carbamazepine in the last case). Three
others were associated with monotherapy (i.e. carba-
mazepine two cases and phenytoin one case). The 10th
one involved a woman who was no longer on any medi-
cation. There was a statistically-significant association
between polytherapy and low birth weight (odds ratio
D 6.0; 2 D 6:62; P  0:001).
When the obstetric and neonatal complications were
analysed according to the ages of the mothers, the two
babies that had congenital malformations were born to
mothers older than 30 years. There was no association
between adverse pregnancy outcome and the duration
of epilepsy in the mothers. Six complications in 37
pregnancies occurred in women who had been epilep-
tic for less than 10 years compared with four out of 32
in women whose duration of epilepsy was more than
10 years (odds ratio D 1.35; 2 D 0:16; P  0:1).
Discussion
The high standard of living, absence of smoking, ab-
sence of hard physical work during pregnancies and
adequate energy reserves at confinement are some
of the factors which have been reported to account
for the documented favourable outcome of pregnan-
cies in Saudi mothers7–10. In addition, hospital care is
free, so patients have access to drugs and investiga-
tions deemed necessary. However, epilepsy constitutes
a medical constraint which can disturb the expected
favourable outcome, more so, when seizures are either
uncontrolled or if complications arise as a result of the
use of AEDs. In fact, some authors consider women
with epilepsy as having high-risk pregnancies5. Ourstudy served to highlight the favourable outcome of
many pregnancies in epileptic women with seizure con-
trol, approximately 67% of them. The complications of
pregnancies in this study group are no different from
results of other studies in non-epileptic mothers in this
environment. Our study, however, emphasized the as-
pect of congenital malformations.
The type of seizure influences the choice of AED al-
though studies have shown that there is no appreciable
difference in the effectiveness of the major AEDs11.
The predominant use of carbamazepine during preg-
nancies in our patients, because of its proven efficacy
in both secondarily generalized and partial seizures,
is similar to the other reports5, 12, 13. The distribution
of AED use in our cases is similar to other studies.
The high frequency of myoclonic seizures warranted
the use of valproic acid in spite of its known associ-
ation with congenital malformations especially neural
tube defects1, 2, 4–6, 14. Although the use of valproic acid
is not absolutely contra-indicated in pregnancy, espe-
cially when the seizures are well-controlled or there
is no alternative, however, such women would require
examination for markers of dysraphism and ultrasonog-
raphy before the 20th week of gestation6, 15. These
were done routinely in our patients and none of the
babies had spina bifida. Despite the regular follow-up
and compliance of these women, seizures were uncon-
trolled in about a third of them. This is not an unusual
proportion, as seizures may be uncontrolled in up to
64% of patients with major seizures in one series13.
The breakthrough attacks are more likely to be due to
sleep deprivation or deliberate non-compliance during
pregnancy. Another reason could be altered drug phar-
macokinetics in pregnancy related to plasma protein
binding1, 2, 5, 16. In such instances, the usually measured
total plasma-drug concentration may be misleading but
the active free-drug concentration may be abnormal
which might cause confusion as regards adjustment of
drug dosages13.
The pattern of obstetric management in this study
is no different from the experiences of others1, 2.
The commonest neonatal problem was: intra-uterine
growth retardation or low birth weight which was asso-
ciated with prematurity, pre-eclamptic toxaemia, con-
genital malformations, maternal old age and polyther-
apy. Maternal age in Saudis of more than 35 years
was associated with a doubled increase in the risk of
low birth weight compared with Swedish mothers in
another study9. Intra-uterine growth retardation and
developmental delay are well-documented as minor
anomalies associated with the use of phenytoin, car-
bamazepine and phenobarbital5. None of the women
were treated with trimethadone which is also associ-
ated with intra-uterine growth retardation5. The higher
proportion of babies with intra-uterine growth retarda-
tion born by epileptic mothers was the only feature that
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The frequency of congenital malformations of 2.5%
in this study group is within the range of 1–6% re-
ported previously2. However, we could not have en-
countered all the possible congenital malformations
because of the small sample size. In spite of this limita-
tion, the association of polytherapy with adverse preg-
nancy outcome was apparent. Polytherapy is associated
with enhanced formation of active metabolites which
overtake the capacity for their elimination and could
result in malformations16. Other possible considera-
tions include genetic predisposition and reduced folate
levels16.
In conclusion, our results showed a slightly higher
frequency of low birth-weight children born by epilep-
tic mothers which was associated with prematurity,
older maternal age and multiple AED usage. The fre-
quency of congenital malformation was within the
range reported in other studies. The use of AED as
monotherapy during pregnancy is a feasible interven-
tion which is essential for reducing the frequency of
prematurity and congenital malformations.References
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